Healthcare IT News May 7, 2021
An artificial intelligence-enabled electrocardiogram helped identify patients with low ejection fraction who previously “would have slipped through the cracks.”
The Mayo Clinic released results of a trial this week that suggests potential for artificial intelligence to assist with early diagnosis of some types of heart disease.
The study, published in Nature Medicine on Thursday, found that an AI-enabled electrocardiogram increased the diagnosis of low ejection fraction.
“The AI-enabled EKG facilitated the diagnosis of patients with low ejection fraction in a real-world setting by identifying people who previously would have slipped through the cracks,” said Dr. Peter Noseworthy, a Mayo Clinic cardiac electrophysiologist who was the senior author on the study, in a press release.
WHY IT MATTERS
...Today's Sponsors
Today's Sponsor